Evidence map›Paper›PMID 37158187›Full record

ArticleHuman vaccines & immunotherapeutics2023

Trends in research related to vaccine and cancer prevention from 1992 to 2022: A 30-years bibliometric analysis.

Luofei Zhang, Kefu Yu, Bin Zhu, Shenghui Mei, Jiping Huo, Zhigang Zhao

Open access · goldAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. The Past and Future of Inflammation as a Target to Cancer Prevention.Cancer prevention research (Philadelphia, Pa.) · 2024
    Article
  7. Review
  8. Bibliometric analysis of RNA vaccines for cancer.Human vaccines & immunotherapeutics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Luofei ZhangDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Kefu YuDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Bin ZhuDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Shenghui MeiDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jiping HuoDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zhigang ZhaoDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNBeijing Tian Tan Hospital · CNCapital University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccines may play an important role in cancer prevention. This bibliometric study in the field of vaccine and cancer prevention is designed to evaluate key research advances, identify existing deficiencies, and provide reference for future investigations. A total of 2916 original articles published in English from 1992 to 2022 were extracted from the Web of Science core collection. America (1,277) and the National Cancer Institute (82) were the most productive country and institution in this field, respectively.

Indexed as

Uterine Cervical NeoplasmsVaccinesBibliometricsFemaleHealth FacilitiesHumansVaccinesBibliometriccancercervical cancerpreventionvaccinevirus

Identifiers

PMID37158187
PMCPMC10294762
OpenAlexW4375954622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.